Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-07-22
2008-07-22
Wilson, James O. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S284000
Reexamination Certificate
active
10499684
ABSTRACT:
The invention provides quinazoline derivatives of formula (I): in the preparation of a medicament for use in the inhibition of Aurora kinase and also novel quinazoline derivatives, processes for their preparation, pharamceutical compositions containing them and their use in therapy
REFERENCES:
patent: 5480883 (1996-01-01), Spada et al.
patent: 5710158 (1998-01-01), Myers et al.
patent: 6610677 (2003-08-01), Davies et al.
patent: 0326330 (2002-07-01), None
patent: WO-92/20642 (1992-11-01), None
patent: WO-95/15758 (1995-06-01), None
patent: 96/09294 (1996-03-01), None
patent: 96/15118 (1996-05-01), None
patent: 96/39145 (1996-12-01), None
patent: WO-96/39145 (1996-12-01), None
patent: WO-97/03069 (1997-01-01), None
patent: 99/06378 (1999-02-01), None
patent: 00/21955 (2000-04-01), None
patent: 00/21955 (2000-04-01), None
patent: WO-00/21955 (2000-04-01), None
patent: 01/21596 (2001-03-01), None
patent: 01/21596 (2001-03-01), None
patent: 01/21597 (2001-03-01), None
patent: WO-01/21597 (2001-03-01), None
patent: 02/00649 (2002-01-01), None
patent: WO-02/00649 (2002-01-01), None
Wilkinson et al., “AZD1152, a Selective Inhibitor of Aurora B Kinase, Inhibits Human Tumor Xenograft Growth by Including Apoptosis”, Clinical CAncer REsearch (2007), 3682-3688, 13(12).
Mortlock et al., “Discovery, Synthesis, and in Vivo Activity of a New Class of Pyrazolylaminoquinazolines as Selective Inhibitors of Aurora B Kinase”. Journal of Medicinal Chemistry (2007), 2213-2224, 50(9).
Heron et al., “SAR and inhibitor complex structure determination of a novel class of potent and specific Aurora kinase inhibitors”. Bioorganic & Medicinal Chemistry Letters (2006), 1320-1323, 16(5).
Jung et al., “Discovery of Novel and Potent Thiazoloquinazolines as Selective Aurora A and B Kinase Inhibitors”. Journal of Medicinal Chemistry (2006), 955-970, 49(3).
Mortlock et al., “Progress in the Development of Selective Inhibitors of Aurora Kinases”. Current Topics in Medicinal Chemistry (2005), 807-821, 5(8).
Jung Frederic Henri
Pasquet Georges Rene
AstraZeneca AB
Truong Tamthom N
Wilson James O.
LandOfFree
Substituted quinazoline derivatives as inhibitors of aurora... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted quinazoline derivatives as inhibitors of aurora..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted quinazoline derivatives as inhibitors of aurora... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3914524